PharmiWeb.com - Global Pharma News & Resources
10-Feb-2022

Physical, Engineering, And Life Sciences Global Market Research Report 2022 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Physical, Engineering, And Life Sciences Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.


The global physical, engineering, and life sciences market is expected to grow from $391.44 billion in 2021 to $443.17 billion in 2022 at a compound annual growth rate (CAGR) of 13.2%. The market is expected to reach $687.28 billion in 2026 at a CAGR of 11.6%.

Major players in the physical, engineering and life sciences market are IQVIA Holdings Inc, Battelle Memorial Institute, Syneos Health Inc, PRA Health Sciences Inc, Charles River Laboratories International Inc, PAREXEL International Corporation, Pharmaceutical Product Development LLC, Medpace Holdings Inc, Albany Molecular Research Inc and Hitachi High Technologies America Inc.

Physical, Engineering, and Life Sciences establishments are engaged in conducting research and experimental development in physical, engineering, and life sciences such as agriculture, environmental, botany, electronics, chemistry, fisheries, forests, mathematics, veterinary and other allied subjects.

Research and development activities of physical engineering and life sciences organizations are funded by public sector organizations and commercial establishments. These organizations monetize their research findings, patents or products to fund their research activities.

The main types of physical, engineering, and life sciences are physical and engineering sciences, and life sciences service. Life Sciences Services assists businesses in reimagining and transforming their IT landscapes into next-generation platforms for all important functions. The various entities involved are organizations, sole traders, partnerships. The different service providers include large enterprise, small and medium enterprise.

A major transformation is under progress in the life science industry. Much of it is driven by the digital transformation which has a powerful re-imagination of the life science industry. Technology firms such as Microsoft, Cisco, IBM, Amazon and Google serve as the driving forces and initiators of digital life sciences transformation.

Mobile computing is poised to support the digitization of health in combination with drug therapy, as well as through stand-alone therapies. Digital transformation can help people more effectively for making decisions on how to run the existing business and position the organization for the future. This rise in digital transformation drive the market growth.

The introduction and advancement of new technologies such as nano sensors, bi-specific antibodies and computational biology have illustrated the progress that can be achieved through collaboration across a variety of disciplines between researchers and organisations.

Collaboration between industry and regulators will promote greater self-regulation rooted in a culture of quality, operational competence and monitoring of results. The FDA has also suggested that it plans to partner with businesses more collaboratively to get products to market faster. collaboration will allow stakeholders to provide more responsive, more cost-effective treatment and better results.

COVID-19 is unprecedented challenge to the global life sciences industry. Pharmaceutical and biotech companies around the globe are working with Governments to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges.

The UK and EU regulators have worked to provide up-to-date guidance in response to the evolving crisis, as well as to support research and development (R&D) that they hope will contain the impact of the spread. The MHRA stated that the safety of trial participants should be the first priority and this will remain its objective. These regulatory challenges can restrain the market growth.

Key Topics Covered:

1. Executive Summary

2. Physical, Engineering, And Life Sciences Market Characteristics

3. Physical, Engineering, And Life Sciences Market Trends And Strategies

4. Impact Of COVID-19 On Physical, Engineering, And Life Sciences

5. Physical, Engineering, And Life Sciences Market Size And Growth

5.1. Global Physical, Engineering, And Life Sciences Historic Market, 2016-2021, $ Billion

5.1.1. Drivers Of The Market

5.1.2. Restraints On The Market

5.2. Global Physical, Engineering, And Life Sciences Forecast Market, 2021-2026F, 2031F, $ Billion

5.2.1. Drivers Of The Market

5.2.2. Restraints On the Market

6. Physical, Engineering, And Life Sciences Market Segmentation

6.1. Global Physical, Engineering, And Life Sciences Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Physical And Engineering Sciences
  • Life Sciences Services

6.2. Global Physical, Engineering, And Life Sciences Market, Segmentation By Entities, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Organizations
  • Sole Traders
  • Partnerships

6.3. Global Physical, Engineering, And Life Sciences Market, Segmentation By Service Provider, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Large Enterprise
  • Small and Medium Enterprise

7. Physical, Engineering, And Life Sciences Market Regional And Country Analysis

7.1. Global Physical, Engineering, And Life Sciences Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7.2. Global Physical, Engineering, And Life Sciences Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Companies Mentioned

  • IQVIA Holdings Inc.
  • Battelle Memorial Institute
  • Syneos Health Inc.
  • PRA Health Sciences Inc.
  • Charles River Laboratories International Inc.
  • PAREXEL International Corporation
  • Pharmaceutical Product Development LLC
  • Medpace Holdings Inc.
  • Albany Molecular Research Inc.
  • Hitachi High Technologies America Inc.
  • PDL BioPharma Inc.
  • Defense Advanced Research Projects Agency
  • Lawrence Livermore National Laboratory LLC
  • Los Alamos National Laboratory
  • AKKA Technologies (France)
  • Qinetiq Group (UK)
  • WuXi Apptec (China)
  • Argonne National Laboratory

For more information about this report visit https://www.researchandmarkets.com/r/w7s2j


Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 10-Feb-2022